Literature DB >> 17008030

Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients.

Riet Dams1, Robin E Choo, Willy E Lambert, Hendree Jones, Marilyn A Huestis.   

Abstract

Interest in oral fluid as an alternative matrix for monitoring drug use is due to its ease-of-collection and non-invasiveness; however, limited data are available on the disposition of drugs into oral fluid. The objective of this research was to provide data on the presence and concentrations of heroin, cocaine and multiple metabolites in oral fluid after illicit opioid and cocaine use. Thrice weekly oral fluid specimens (N=403) from 16 pregnant opiate-dependent women were obtained with the Salivette oral fluid collection device. Evidence of heroin (N=62) and cocaine (N=130) use was detected in oral fluid by LC-APCI-MS/MS. 6-Acetylmorphine (6-AM), heroin and morphine were the major opiates detected, with median concentrations of 5.2, 2.3, and 7.5 microg/L, respectively. Cocaine and benzoylecgonine (BE) had median concentrations of 6.4 and 3.4 microg/L. Application of the Substance Abuse Mental Health Services Administration (SAMHSA) recommended cutoffs for morphine and codeine (40 microg/L), 6-AM (4 microg/L) and cocaine and BE (8 microg/L), yielded 28 opiate- and 50 cocaine-positive specimens. Oral fluid is a promising alternative matrix to monitor opiate and cocaine use in drug testing programs. These data guide interpretation of oral fluid test results and evaluate currently proposed SAMHSA oral fluid testing cutoffs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008030      PMCID: PMC1892788          DOI: 10.1016/j.drugalcdep.2006.08.020

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  49 in total

1.  Saliva/plasma ratio of methadone and EDDP.

Authors:  A M Bermejo; A C Lucas; M J Tabernero
Journal:  J Anal Toxicol       Date:  2000 Jan-Feb       Impact factor: 3.367

Review 2.  Techniques for analytical testing of unconventional samples.

Authors:  L Rivier
Journal:  Baillieres Best Pract Res Clin Endocrinol Metab       Date:  2000-03

3.  On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.

Authors:  N Samyn; C van Haeren
Journal:  Int J Legal Med       Date:  2000       Impact factor: 2.686

4.  LC-atmospheric pressure chemical ionization-MS/ MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation.

Authors:  Riet Dams; Constance M Murphy; Robin E Choo; Willy E Lambert; Andre P De Leenheer; Marilyn A Huestis
Journal:  Anal Chem       Date:  2003-02-15       Impact factor: 6.986

5.  Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.

Authors:  Gail Cooper; Lisa Wilson; Claire Reid; Lianne Main; Chris Hand
Journal:  Forensic Sci Int       Date:  2005-04-15       Impact factor: 2.395

6.  Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis.

Authors:  E T Moolchan; E J Cone; A Wstadik; M A Huestis; K L Preston
Journal:  J Anal Toxicol       Date:  2000-10       Impact factor: 3.367

Review 7.  Oral fluid collection: the neglected variable in oral fluid testing.

Authors:  Dennis J Crouch
Journal:  Forensic Sci Int       Date:  2005-06-10       Impact factor: 2.395

8.  Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid.

Authors:  Riet Dams; Marilyn A Huestis; Willy E Lambert; Constance M Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2003-11       Impact factor: 3.109

9.  Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.

Authors:  Raf J F Schepers; Jonathan M Oyler; Robert E Joseph; Edward J Cone; Eric T Moolchan; Marilyn A Huestis
Journal:  Clin Chem       Date:  2003-01       Impact factor: 8.327

10.  Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration.

Authors:  Insook Kim; Allan J Barnes; Jonathan M Oyler; Raf Schepers; Robert E Joseph; Edward J Cone; Diana Lafko; Eric T Moolchan; Marilyn A Huestis
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

View more
  14 in total

Review 1.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

Review 2.  Modern instrumental methods in forensic toxicology.

Authors:  Michael L Smith; Shawn P Vorce; Justin M Holler; Eric Shimomura; Joe Magluilo; Aaron J Jacobs; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2007-06       Impact factor: 3.367

3.  The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Remy L Brim; Kathleen R Noon; Gregory T Collins; Joseph Nichols; Diwahar Narasimhan; Roger K Sunahara; James H Woods
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

Review 4.  Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?

Authors:  Krishnan Chakravarthy; Aneesh Goel; George M Jeha; Alan David Kaye; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2021-02-17

5.  Applying total internal reflection excitation and super critical angle fluorescence detection to a morphine assay.

Authors:  Hannu S Välimäki; Timo Pulli; Kirsi Tappura
Journal:  J Fluoresc       Date:  2010-04-13       Impact factor: 2.217

Review 6.  Objective Testing: Urine and Other Drug Tests.

Authors:  Scott E Hadland; Sharon Levy
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2016-03-30

7.  A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.

Authors:  Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

8.  Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human oral fluid.

Authors:  Diaa M Shakleya; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2009-10-18       Impact factor: 4.142

9.  Monitoring pregnant women's illicit opiate and cocaine use with sweat testing.

Authors:  Bertrand R Brunet; Allan J Barnes; Robin E Choo; Patrick Mura; Hendre E E Jones; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2010-02       Impact factor: 3.681

Review 10.  Oral fluid testing for drugs of abuse.

Authors:  Wendy M Bosker; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-09-10       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.